Ebola
Ebola

wpid-Ebola20in20Malasia-20official.jpgResearchers at the University of Liverpool have disclosed that they have made a discovery?that can lead to a cure of the deadly Ebola Virus Disease, EVD.

In an announcement on Saturday, the researchers informed that they have stumbled across an existing drug used in the treatment of severe heart disease, which could be adapted to fight the contagious virus.

The team from the Health Protection Research Unit at the University of Liverpool?s Institute of Infection and Global Health, according to Xinhua?reports, collaborated with the Public Health England to look at how Ebola virus hijacks proteins inside cells, and then seek ways to stop this from happening.

It was gathered that the?experts looked at what proteins inside a cell are critical for the functions of Ebola virus and are hijacked by the virus to help with infection. One of the proteins they have targeted is known as VP24.

This protein disrupts signaling in infected human cells and disrupts the body?s immune system and the fight against the virus.

The Liverpool team then tried to find out if any existing drugs are available that could block the function of this particular protein.

And to their amazement they found the heart drug ?ouabain?. This drug when administered can reduce the virus? replication.

According to the?team, further tests need to be done to ascertain the efficacy of the drug, but as the heart drug is already in use, much of the work to test whether it is safe for humans has already been completed.

This, they said, would potentially speed up the time it could take get the treatment to Ebola patients in need.

Speaking on their study,?Julian Hiscox from the university?s Institute of Infection and Global Health, who led the research, said: ?This study shows how existing therapeutics can be identified and potentially repurposed for anti-viral therapy.

?The technique of using existing and tested drugs for a different purpose can save considerable time and ultimately, lives?.

Few months ago, Canadian scientists also announced that a drug for the treatment of Ebola virus has passed the first test to confirm its efficacy.

The EVD, formerly known as Ebola hemorrhagic fever is a severe condition caused by a virus from the Filoviridae family.

Known to be a condition that is transmitted from animals to humans, this virus spreads through direct contact with the bodily fluids of an infected person or animal.

It would be recalled that since the epidemic outbreak in the West Africa early 2014, scientists and medical experts have been trying hard?to fight the deadly Ebola virus and limit its spread.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.